Age-related Cognitive Decline Clinical Trial
Official title:
Effectiveness Of Computer-Based Cognitive Training Combined With Aerobic Training in Age-Related Cognitive Decline
Verified date | January 2024 |
Source | University of Jazan |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Background: Ageing is frequently accompanied by physiological changes that might result in a deterioration in physical and cognitive abilities, which frequently leads to institutionalization or the loss of autonomy. Mild cognitive impairment (MCI) is an intermediate state between normal cognitive aging and early dementia, the optimal period to intervene with preventive strategies and early treatments. Thus, the current study intends to investigate the effects of aerobic and computer-based cognitive training on age-related cognitive decline. Methods: This is a single-blinded, randomized controlled trial. Elderly patients with mild cognitive impairment (n = 60) will be randomized to 2 arms and treated for 12 weeks: arm 1 (aerobic exercise and computerized cognitive training) and arm 2 (Placebo; will not receive any intervention). Outcome measure used were Montreal Cognitive Assessment (MOCA) test, Barthel Index (BI) and short form survey-12 (SF-12). Statistical Analysis: To compare the baseline characteristics and outcome variables between the two groups, independent t-tests was employed. A two-way repeated measures ANOVA was utilized to determine the interaction effect of time (baseline, post-treatment, and follow-up) and group (intervention vs. control) on the outcome measures.
Status | Completed |
Enrollment | 60 |
Est. completion date | October 30, 2023 |
Est. primary completion date | September 15, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 60 Years to 85 Years |
Eligibility | Inclusion Criteria: - Who fulfilled MCI criteria [10]: (1) subjective cognitive concerns; (2) objective cognitive impairment in memory, executive function, attention, and/or language; (3) preserved activities of daily living; and (4) absence of dementia - Literate - Had adequate visual, auditory, and fine motor skills. Exclusion Criteria: - Major depression (scored > 9 in the Geriatric Depression Scale, GDS-15) [11] - Schizophrenia - Substance abuse - parkinsonism - conditions affecting gait (eg, severe osteoarthritis, previous stroke), - participated in any cognitive training program during last 6 months > 2 h/week - ACSM contraindications to exercise or other factors that make exercise impossible or unsafe - cognitive enhancers, or anticholinergics |
Country | Name | City | State |
---|---|---|---|
Saudi Arabia | Jazan University | Jazan |
Lead Sponsor | Collaborator |
---|---|
University of Jazan |
Saudi Arabia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Montreal Cognitive Assessment test | A commonly used test to assess different cognitive domains, including short-term memory recall, visuospatial abilities, executive functions, attention, concentration, and working memory. MoCA scores range between 0 and 30 where the highest score is considered to be normal. | at the baseline (day 0), at the end of the treatment (after 12 weeks) as well as after 4 weeks of follow up (after 16 weeks) | |
Primary | Barthel Index | This index was used to measure an individual's capacity to perform ten activities of daily living, reflecting their functional independence. Total possible scores range from 0 - 20, with lower scores indicating increased disability. | at the baseline (day 0), at the end of the treatment (after 12 weeks) as well as after 4 weeks of follow up (after 16 weeks) | |
Primary | Short form survey-12 | A generic measure utilized to assess the health-related quality of life, covering both physical and mental health dimensions. The summary scores range from a minimum of 0 to a maximum of 100. Higher the SF-12 scores, indicates the higher (better) quality of life. | at the baseline (day 0), at the end of the treatment (after 12 weeks) as well as after 4 weeks of follow up (after 16 weeks) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04121728 -
Modulation of Attention in Event Related Potential (ERPs) as a Marker of Early Cognitive Decline by Ginkgo Biloba
|
N/A | |
Enrolling by invitation |
NCT04641663 -
Multi-target Dietary Supplement Tolerability in an Aging Population (MTDSST)
|
N/A | |
Completed |
NCT03228446 -
The Effects of Attentional Filter Training on Working Memory
|
N/A | |
Completed |
NCT04910399 -
Development of an Innovative Health Ingredient From Marine By-products for the Healthy Aging
|
N/A | |
Recruiting |
NCT03275363 -
The University of Hong Kong Neurocognitive Disorder Cohort
|
N/A | |
Completed |
NCT02185222 -
Effect of Vitamin D on Cognitive Decline of Patients With Memory Complaint
|
Phase 3 | |
Completed |
NCT03162913 -
The Effects of Strawberry Supplementation on Memory and Gait Among Over-weight Older Adults
|
N/A | |
Completed |
NCT02416401 -
Attention Training for Learning Enhancement and Resilience Trial
|
N/A | |
Completed |
NCT02922920 -
Effects of Tart Cherry Juice on the Body
|
N/A | |
Completed |
NCT01120860 -
Magnetic Resonance Imaging (MRI) and Decline of Aging Aviator Performance
|
N/A | |
Recruiting |
NCT03702335 -
Impact of Comprehensive Dietary Counseling on Dietary Quality, Mental Health, and Quality of Life in Older Adults
|
N/A | |
Completed |
NCT05828043 -
Brain Aging: Muscle-to-brain Axis Modulates Physio-cognitive Decline
|
N/A | |
Active, not recruiting |
NCT05348694 -
OsteoPreP: Food Supplements for Postmenopausal Bone Health
|
Phase 4 | |
Recruiting |
NCT05194787 -
TAS Test: Online Motor-cognitive Tests for Early Detection of Alzheimer's Disease
|
||
Recruiting |
NCT04184375 -
Cognitive Stimulation for Elderly Bipolar Patients
|
N/A | |
Recruiting |
NCT04171323 -
The Active Mind Trial: An Adaptive Randomized Trial to Improve Function and Delay Dementia
|
N/A | |
Not yet recruiting |
NCT06248723 -
ItaliaN Study With Tailored Multidomain Interventions to Prevent Functional and Cognitive Decline in Community-dwelling Older Adults
|
N/A | |
Terminated |
NCT04732312 -
Impact of Formal Home Help on Quality of Life for Caregivers of Elderly Patients With Neurocognitive Impairment
|
||
Recruiting |
NCT06377254 -
Multi-organ Responses to CHronic Physical Activity and INactivity
|
N/A | |
Not yet recruiting |
NCT04566757 -
Safety and Efficacy of Human Umbilical Cord Blood Plasma Infusion for Age-Related Cognitive Decline
|
Phase 1 |